Table 2.
Resolution of comorbidities by 12 months postoperatively among the studied patients
| O’perative data | 2 cm. pylorus (N = 48) | 6 cm. pylorus (N = 48) | P-Value | |||
|---|---|---|---|---|---|---|
| Comorbidity | Count | % | Count | % | ||
| Diabetes | Cured | 24 | 80% | 22 | 78.5% | 0.37 |
| Improved | 6 | 20% | 6 | 21.5 | ||
| Hypertension | Cured | 12 | 75% | 10 | 71.4% | 0.51 |
| Improved | 4 | 25% | 4 | 28.6% | ||
| Hyperlipidemia | Cured | 30 | 71.4% | 26 | 65% | 0.43 |
| Improved | 12 | 28.6% | 14 | 35% | ||
| GERDa | Cured | 12 | 75% | 12 | 66.67% | 0.28 |
| Improved | 2 | 12.5% | 4 | 22.22% | ||
| Unchanged | 2 | 12.5% | 2 | 11.11% | ||
| OSASb | Cured | 2 | 50% | 4 | 66.67% | 0.94 |
| Improved | 2 | 50% | 2 | 33.33% | ||
| Depression | Cured | 22 | 100% | 26 | 100% | 0.96 |
| OAc | Cured | 16 | 50% | 14 | 50% | 0.81 |
| Improved | 12 | 37.5% | 10 | 35.72% | ||
| Unchanged | 4 | 12.5% | 4 | 14.28% | ||
aGERD Gastroesophageal reflux disease
bOSAS Obstructive sleep apnea syndrome
cOA Osteoarthritis